Literature DB >> 32322288

Correction to: The effect of western diet on mice brain lipid composition.

Alicja Pakiet1, Agnieszka Jakubiak2, Aleksandra Czumaj3, Tomasz Sledzinski3, Adriana Mika1,3.   

Abstract

[This corrects the article DOI: 10.1186/s12986-019-0401-4.].
© The Author(s) 2020.

Entities:  

Year:  2020        PMID: 32322288      PMCID: PMC7161234          DOI: 10.1186/s12986-020-00444-0

Source DB:  PubMed          Journal:  Nutr Metab (Lond)        ISSN: 1743-7075            Impact factor:   4.169


Correction to: Nutr Metab https://doi.org/10.1186/s12986-019-0401-4 The original version of this article [1], published on 27 November 2019, contained incorrect calculations. In this Correction the affected part of the article is shown. 1. Incorrect calculations in Table 2 Composition of polyunsaturated FAs in major tissues;
Table 2

Composition of polyunsaturated FAs in major tissues

Chow [μg/kg]Serum [μg/L]Brain [%]Liver [%]Retroperitoneal adipose tissue [%]Epididymal adipose tissue [%]Subcutaneous adipose tissue [%]
10%60%SDHFDSDHFDSDHFDSDHFDSDHFDSDHFD
SFA 205.08 671.00 971.92 ± 253.18 1766.61 ± 353.61# 46.13 ± 1.06 46.82 ± 2.14 37.41 ± 0.86 38.03 ± 4.72 33.75 ± 2.46 29.73 ± 1.64* 29.08 ± 1.53 29.28 ± 1.63 31.99 ± 1.39 28.80 ± 2.29*
MUFA 131.09 455.75 1079.97 ± 340.71 1227.99 ± 244.16 32.35 ± 2.64 30.99 ± 2.75 41.26 ± 2.56 39.15 ± 11.23 62.51 ± 2.16 62.06 ± 1.73 66.86 ± 1.29 62.58 ± 1.43* 64.19 ± 1.44 63.03 ± 2.17
16:2 n-60.10 ± 0.020.40 ± 0.150.01 ± 0.000.01 ± 0.010.003 ± 0.0000.020 ± 0.010*0.01 ± 0.000.01 ± 0.010.01 ± 0.000.01 ± 0.00*0.003 ± 0.0000.02 ± 0.01#
LA25.8395.00329.16 ± 24.65870.96 ± 105.11#0.38 ± 0.080.72 ± 0.08#6.40 ± 0.4611.56 ± 2.34*3.02 ± 0.287.46 ± 0.10#3.42 ± 0.517.51 ± 0.31#3.16 ± 0.177.51 ± 0.15#
20:2 n-60.890.403.39 ± 0.488.88 ± 2.05#0.08 ± 0.020.15 ± 0.03*0.09 ± 0.010.17 ± 0.05*0.07 ± 0.010.14 ± 0.03#0.05 ± 0.010.11 ± 0.02#0.05 ± 0.010.11 ± 0.02#
DGLA0.261.2529.86 ± 5.5134.00 ± 13.690.35 ± 0.040.38 ± 0.011.35 ± 0.110.65 ± 0.17#0.08 ± 0.020.06 ± 0.00*0.05 ± 0.010.03 ± 0.02*0.07 ± 0.010.04 ± 0.01*
ARA0.481.75140.57 ± 30.17313.94 ± 49.40#7.93 ± 0.618.11 ± 0.648.19 ± 0.876.28 ± 2.830.10 ± 0.030.10 ± 0.020.06 ± 0.020.04 ± 0.030.11 ± 0.020.07 ± 0.02*
AdA0.110.751.37 ± 0.202.81 ± 0.534*2.06 ± 0.252.01 ± 0.250.14 ± 0.020.17 ± 0.050.02 ± 0.010.01 ± 0.00*0.01 ± 0.010.01 ± 0.000.01 ± 0.010.01 ± 0.00
PUFA n-6 27.76 103.13 509.63 ± 50.28 1232.70 ± 99.52# 11.22 ± 0.96 11.52 ± 0.64 16.62 ± 1.38 18.93 ± 5.24 3.30 ± 0.32 7.79 ± 0.09# 3.61 ± 0.53 7.72 ± 0.23# 3.42 ± 0.18 7.77 ± 0.19#
ALA0.070.255.24 ± 1.809.52 ± 2.24*0.02 ± 0.010.02 ± 0.010.10 ± 0.030.18 ± 0.06*0.01 ± 0.010.01 ± 0.010.01 ± 0.000.01 ± 0.010.01 ± 0.010.01 ± 0.00
ETA2.53 ± 0.432.37 ± 0.650.06 ± 0.010.03 ± 0.01*0.01 ± 0.000.01 ± 0.000.01 ± 0.000.01 ± 0.010.01 ± 0.000.01 ± 0.00
EPA0.190.5039.66 ± 9.4718.94 ± 2.29#0.33 ± 0.030.15 ± 0.02 #1.71 ± 0.120.31 ± 0.11#0.12 ± 0.020.03 ± 0.00#0.13 ± 0.020.05 ± 0.04#0.12 ± 0.020.02 ± 0.01#
DPA0.190.632.61 ± 0.397.59 ± 1.90#0.36 ± 0.050.31 ± 0.060.23 ± 0.040.32 ± 0.090.03 ± 0.010.02 ± 0.010.02 ± 0.010.01 ± 0.000.03 ± 0.010.01 ± 0.00#
DHA0.040.2528.40 ± 6.7468.66 ± 7.68#8.91 ± 0.579.71 ± 0.782.36 ± 0.292.85 ± 1.280.03 ± 0.010.01 ± 0.01*0.02 ± 0.000.01 ± 0.010.02 ± 0.000.01 ± 0.00
PUFA n-3 0.48 1.63 78.43 ± 17.61 108.08 ± 8.18* 9.62 ± 0.60 10.19 ± 0.79 4.46 ± 0.37 3.69 ± 1.50 0.20 ± 0.04 0.08 ± 0.01# 0.19 ± 0.01 0.10 ± 0.06* 0.18 ± 0.02 0.06 ± 0.02#

p-value from t-test: * < 0.05, # < 0.001, AdA – adrenic acid (22:4 n-6), ALA – α-linolenic acid (18:3 n-3), ARA – arachidonic acid (20:4 n-6), DGLA –dihomo-γ-linolenic acid (20:3 n-6), DHA – docosahexaenoic acid (22:6 n-3), DPA – docosapentaenoic acid (22:5 n-3), EPA – eicosapentaenoic acid (20:5 n-3), ETA – eicosatetraenoic acid (20:4 n-3), LA – linoleic acid (18:2 n-6), MUFA – monounsaturated fatty acids, PUFA – polyunsaturated fatty acids, SFA – saturated fatty acid

Boldface, major groups of fatty acid

Composition of polyunsaturated FAs in major tissues p-value from t-test: * < 0.05, # < 0.001, AdA – adrenic acid (22:4 n-6), ALA – α-linolenic acid (18:3 n-3), ARA – arachidonic acid (20:4 n-6), DGLA –dihomo-γ-linolenic acid (20:3 n-6), DHA – docosahexaenoic acid (22:6 n-3), DPA – docosapentaenoic acid (22:5 n-3), EPA – eicosapentaenoic acid (20:5 n-3), ETA – eicosatetraenoic acid (20:4 n-3), LA – linoleic acid (18:2 n-6), MUFA – monounsaturated fatty acids, PUFA – polyunsaturated fatty acids, SFA – saturated fatty acid Boldface, major groups of fatty acid 2. Correct calculations in Table 2 Composition of polyunsaturated FAs in major tissues;
Table 2

Composition of polyunsaturated FAs in major tissues

Chow [mg/g]Serum [mg/L]Brain [%]Liver [%]Retroperitoneal adipose tissue [%]Epididymal adipose tissue [%]Subcutaneous adipose tissue [%]
10%60%SDHFDSDHFDSDHFDSDHFDSDHFDSDHFD
SFA 17.9 ± 0.64 136 ± 8.00** 1049 ± 286 1855 ± 397** 46.13 ± 1.06 46.82 ± 2.14 37.41 ± 0.86 38.03 ± 4.72 33.75 ± 2.46 29.73 ± 1.64* 29.08 ± 1.53 29.28 ± 1.63 31.99 ±1.39 28.80 ±.29*
MUFA 10.7 ± 0.12 87.9 ± 4.15# 1164 ± 389 1289 ± 274 32.35 ± 2.64 30.99 ± 2.75 41.26 ± 2.56 39.15 ± 11.23 62.51 ± 2.16 62.06 ± 1.73 66.86 ± 1.29 62.58 ± 1.43* 64.19 ± 1.44 63.03 ±2.17
16:2 n-60.067 ± 0.0030.51 ± 0.02#0.04 ± 0.060.40 ± 0.17**0.01 ± 0.000.01 ± 0.010.003 ± 0.0000.020 ± 0.010*0.01 ± 0.000.01 ± 0.010.01 ± 0.000.01 ± 0.00*0.003 ± 0.0000.02 ±0.01#
LA2.04 ± 0.0418.6 ± 0.70#356 ± 29.1915 ± 114#0.38 ± 0.080.72 ± 0.08#6.40 ± 0.4611.56 ± 2.34*3.02 ± 0.287.46 ± 0.10#3.42 ± 0.517.51 ± 0.31#3.16 ± 0.177.51 ± 0.15#
20:2 n-60.058 ± 0.0090.57 ± 0.07**3.78 ± 0.639.22 ± 2.37**0.08 ± 0.020.15 ± 0.03*0.09 ± 0.010.17 ± 0.05*0.07 ± 0.010.14 ± 0.03#0.05 ± 0.010.11 ± 0.02#0.05 ± 0.010.11 ± 0.02#
DGLA0.012 ± 0.00020.11 ± 0.01**32.4 ± 6.8336.0 ± 16.20.35 ± 0.040.38 ± 0.011.35 ± 0.110.65 ± 0.17#0.08 ± 0.020.06 ± 0.00*0.05 ± 0.010.03 ± 0.02*0.07 ± 0.010.04 ± 0.01*
ARA0.037 ± 0.0040.36 ± 0.01#152 ± 37.4330 ± 59.2#7.93 ± 0.618.11 ± 0.648.19 ± 0.876.28 ± 2.830.10 ± 0.030.10 ± 0.020.06 ± 0.020.04 ± 0.030.11 ± 0.020.07 ± 0.02*
AdA0.008 ± 0.0020.11 ± 0.02*1.48 ± 0.352.81 ± 0.60#2.06 ± 0.252.01 ± 0.250.14 ± 0.020.17 ± 0.050.02 ± 0.010.01 ± 0.00*0.01 ± 0.010.01 ± 0.000.01 ± 0.010.01 ± 0.00
PUFA n-6 2.16 ± 0.03 19.7 ± 0.64# 552 ± 63.9 1295 ± 105# 11.22 ± 0.96 11.52 ± 0.64 16.62 ± 1.38 18.93 ± 5.24 3.30 ± 0.32 7.79 ± 0.09# 3.61 ± 0.53 7.72 ± 0.23# 3.42 ± 0.18 7.77 ± 0.19#
ALA0.005 ± 0.0020.049 ± 0.002#5.74 ± 2.189.97 ± 2.55*0.02 ± 0.010.02 ± 0.010.10 ± 0.030.18 ± 0.06*0.01 ± 0.010.01 ± 0.010.01 ± 0.000.01 ± 0.010.01 ± 0.010.01 ± 0.00
ETA0.002 ± 0.0010.01 ± 0.012.87 ± 0.563.44 ± 0.890.06 ± 0.010.03 ± 0.01*0.01 ± 0.000.01 ± 0.000.01 ± 0.000.01 ± 0.010.01 ± 0.000.01 ± 0.00
EPA0.008 ± 0.0020.074 ± 0.004#42.9 ± 11.720.1 ± 2.77**0.33 ± 0.030.15 ± 0.02 #1.71 ± 0.120.31 ± 0.11#0.12 ± 0.020.03 ± 0.00#0.13 ± 0.020.05 ± 0.04#0.12 ± 0.020.02 ± 0.01#
DPA0.016 ± 0.0030.15 ± 0.007#2.81 ± 0.537.87 ± 2.28**0.36 ± 0.050.31 ± 0.060.23 ± 0.040.32 ± 0.090.03 ± 0.010.02 ± 0.010.02 ± 0.010.01 ± 0.000.03 ± 0.010.01 ± 0.00#
DHA0.006 ± 0.0030.06 ± 0.0230.9 ± 8.2472.1 ± 8.818.91 ± 0.579.71 ± 0.782.36 ± 0.292.85 ± 1.280.03 ± 0.010.01 ± 0.01*0.02 ± 0.000.01 ± 0.010.02 ± 0.000.01 ± 0.00
PUFA n-3 0.04 ± 0.01 0.35 ± 0.007# 85.2 ± 21.7 114 ± 9.01* 9.62 ± 0.60 10.19 ± 0.79 4.46 ± 0.37 3.69 ± 1.50 0.20 ± 0.04 0.08 ± 0.01# 0.19 ± 0.01 0.10 ± 0.06* 0.18 ± 0.02 0.06 ± 0.02#

p-value from paired t-test: * < 0.05, # < 0.001, AdA – adrenic acid (22:4 n-6), ALA – α-linolenic acid (18:3 n-3), ARA – arachidonic acid (20:4 n-6), DGLA –dihomo-γ-linolenic acid (20:3 n-6), DHA – docosahexaenoic acid (22:6 n-3), DPA – docosapentaenoic acid (22:5 n-3), EPA – eicosapentaenoic acid (20:5 n-3), ETA – eicosatetraenoic acid (20:4 n-3), LA – linoleic acid (18:2 n-6), MUFA – monounsaturated fatty acids, PUFA – polyunsaturated fatty acids, SFA – saturated fatty acid

Boldface, major groups of fatty acid

Composition of polyunsaturated FAs in major tissues p-value from paired t-test: * < 0.05, # < 0.001, AdA – adrenic acid (22:4 n-6), ALA – α-linolenic acid (18:3 n-3), ARA – arachidonic acid (20:4 n-6), DGLA –dihomo-γ-linolenic acid (20:3 n-6), DHA – docosahexaenoic acid (22:6 n-3), DPA – docosapentaenoic acid (22:5 n-3), EPA – eicosapentaenoic acid (20:5 n-3), ETA – eicosatetraenoic acid (20:4 n-3), LA – linoleic acid (18:2 n-6), MUFA – monounsaturated fatty acids, PUFA – polyunsaturated fatty acids, SFA – saturated fatty acid Boldface, major groups of fatty acid
  1 in total

1.  The effect of western diet on mice brain lipid composition.

Authors:  Alicja Pakiet; Agnieszka Jakubiak; Aleksandra Czumaj; Tomasz Sledzinski; Adriana Mika
Journal:  Nutr Metab (Lond)       Date:  2019-11-27       Impact factor: 4.169

  1 in total
  1 in total

Review 1.  A Bidirectional View of Migraine and Diet Relationship.

Authors:  Parisa Gazerani
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-11       Impact factor: 2.570

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.